Condition
Salivary Gland Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Salivary Gland Cancer clinical trials that are recruiting, at sites in 8 countries (most in United States (7), Czechia (1), Germany (1)). By phase: Phase 2 (4), Phase 1/2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 8Countries
Newest Salivary Gland Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Docetaxel and SX-682 in head and neck cancers and prostate cancer | Phase 1/2 | Bethesda, Maryland | Recruiting | Jun 25, 2026 |
| Testing trastuzumab deruxtecan (T‑DxD) for HER2‑positive advanced solid tumors | — | Birmingham, Alabama and 17 other locations | Recruiting | Aug 15, 2025 |
| Sacituzumab govitecan for advanced salivary gland and differentiated thyroid cancers | Phase 2 | Singapore | Recruiting | Apr 11, 2025 |
| Evaluating Ivonescimab for advanced salivary gland cancers | Phase 2 | Boston, Massachusetts and 1 other locations | Recruiting | Feb 3, 2025 |
| Evaluating zanidatamab for HER2-expressing tumors | Phase 2 | Prescott, Arizona and 41 other locations | Recruiting | Nov 19, 2024 |
| Implantable microdevice drug screening for salivary and head and neck cancers | Early Phase 1 | Boston, Massachusetts and 1 other locations | Recruiting | Sep 23, 2022 |
| Registry for rare head and neck cancers in Europe | — | Brno, Brno and 9 other locations | Recruiting | Aug 2, 2022 |
| Using T-DM1 with chemotherapy and radiation for HER2-positive salivary gland cancer after surgery | Phase 2 | Atlanta, Georgia and 12 other locations | Recruiting | Nov 6, 2020 |
| A resource for collecting cancer data and biospecimens | — | Greenwood Village, Colorado and 41 other locations | Recruiting | Dec 16, 2013 |
All recruiting trials (9)
-
Docetaxel and SX-682 in head and neck cancers and prostate cancer
This trial tests a new drug SX-682 together with docetaxel in adults whose head and neck cancers or prostate cancer have returned or spread.
-
Testing trastuzumab deruxtecan (T‑DxD) for HER2‑positive advanced solid tumors
This will test whether trastuzumab deruxtecan (T‑DxD) helps adults in the US with HER2‑positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have had prior systemic treatment and have no satisfactory alternative options.
-
Sacituzumab govitecan for advanced salivary gland and differentiated thyroid cancers
This study will try sacituzumab govitecan in adults whose salivary gland cancer or radioactive-iodine–refractory differentiated thyroid cancer has spread or come back and cannot be removed by surgery.
-
Evaluating Ivonescimab for advanced salivary gland cancers
This study is testing a new treatment called Ivonescimab to see if it can help people with advanced salivary gland cancers feel better and improve their health.
-
Evaluating zanidatamab for HER2-expressing tumors
This study is testing a new drug called zanidatamab to see if it can help people with certain types of cancer that have high levels of HER2 and who have already tried other treatments without success.
-
Implantable microdevice drug screening for salivary and head and neck cancers
This will test whether a tiny implantable microdevice can safely and quickly deliver and screen multiple cancer drugs inside salivary gland and other head and neck tumors in patients scheduled for surgical removal.
-
Registry for rare head and neck cancers in Europe
This study is collecting information on rare head and neck cancers to better understand them and improve treatment and care for patients across Europe.
-
Using T-DM1 with chemotherapy and radiation for HER2-positive salivary gland cancer after surgery
This study is testing if adding a new drug called T-DM1 to regular chemotherapy and radiation can help people with HER2-positive salivary gland cancer stay cancer-free after surgery.
-
A resource for collecting cancer data and biospecimens
This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.
Related topics
Quick answers
How many Salivary Gland Cancer clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (7 trials), Czechia (1 trial), Germany (1 trial), Italy (1 trial), Georgia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.